BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3657717)

  • 1. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
    Trifunović S; Pavlović K
    Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
    Beyerle A; Rudolph W
    Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of myocardial ischemia with molsidomine].
    Dirschinger J; Beyerle A; Rudolph W
    Med Klin (Munich); 1990 Mar; 85(3):141-4. PubMed ID: 2186260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
    Vakaliuk IP
    Ter Arkh; 1986; 58(12):49-50. PubMed ID: 3824212
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of molsidomine on the conjunctival microcirculation in patients with ischemic heart disease].
    Brovko EA; Denisiuk VI; Kolesnik PF
    Vrach Delo; 1989 Nov; (11):49-51. PubMed ID: 2609586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris].
    Sinkiewicz W; Dziedziczko A
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):80-2. PubMed ID: 8361895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems in long-term therapy of coronary heart disease: pharmacotherapy].
    Gilfrich HJ
    Med Klin (Munich); 1987 Jan; 1():29-32. PubMed ID: 3106752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
    Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
    Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiac function during adrenergic beta receptor blockade in different types of angina pectoris and local reversible myocardial ischemia of varying duration (clinico-experimental studies)].
    Ol'binskaia LI; Bragina GI; Litvitskiĭ PF
    Ter Arkh; 1980; 52(5):50-4. PubMed ID: 6105728
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transcutaneous application of nitroglycerin and isosorbide dinitrate versus placebo: effect in myocardial ischemia].
    Gloor HO; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1985 Mar; 115(12):412-7. PubMed ID: 3922052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary heart disease. Hemodynamic response to exercise before and after nitroglycerin.
    Di Giorgi S; West RO; Parker JO
    Mal Cardiovasc; 1968; 9(1):29-50. PubMed ID: 4981691
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute and long-term effects of placebo and molsidomine on pulmonary artery pressure and on workload in patients with coronary heart disease].
    Jansen W; Osterspey A; Schell U; Tauchert M
    Schweiz Rundsch Med Prax; 1986 Oct; 75(41):1210-4. PubMed ID: 3787007
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molsidomine in rest and exercise conditions in coronary heart disease. Acute and long-term effects].
    Jansen W; Meyer L; Osterspey A; Eggeling T; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Jun; 81(14):489-95. PubMed ID: 3097469
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
    Sidorenko BA; Lupanov VP; Kulikova TV; Nekrutman EA; Matveeva LS
    Klin Med (Mosk); 1984 Nov; 62(11):44-51. PubMed ID: 6151611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.